Comparison of Signalment, Clinicopathologic Findings, Histologic Diagnosis, and Prognosis in Dogs with Glomerular Disease with or without Nephrotic Syndrome

Journal of Veterinary Internal Medicine

Volumn 25, Issue 2, 2011, Pages 206-214

  Klosterman, E S ^a   Moore, G E ^a   de Brito Galvao, J F ^b   Dibartola, S P ^b   Groman, R P ^c   Whittemore, J C ^d   Vaden, S L ^e   Harris, T L ^e   Byron, J K ^f   Dowling, S R ^f   Grant, D C ^g   Grauer, G F ^h   Pressler, B M ^a  

^a PURDUE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^h KANSAS STATE UNIVERSITY   (United States)

Author keywords

Amyloidosis; Ascites; Membranoproliferative glomerulonephritis; Membranous glomerulopathy

Indexed keywords

CREATININE;

ALBUMINURIA; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; DOG; DOG DISEASE; FEMALE; GLOMERULUS; KIDNEY DISEASE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; METABOLISM; MORTALITY; MULTICENTER STUDY; NEPHROTIC SYNDROME; PATHOLOGY; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; UREMIA;

ALBUMINURIA; ANIMALS; AZOTEMIA; CASE-CONTROL STUDIES; CREATININE; DOG DISEASES; DOGS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; NEPHROTIC SYNDROME; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS;

EID: 79952340220     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2010.0669.x     Document Type: Article

References (41)

1. Abrass CK. Clinical spectrum and complications of the nephrotic syndrome. J Investig Med 1997;45:143-153.
2. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 1998;338:1202-1211.
3. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res 2005;122:13-28.
4. de Seigneux S, Martin PY. Management of patients with nephrotic syndrome. Swiss Med Wkly 2009;139:416-422.
5. Buemi M, Nostro L, Crasci E, et al. Statins in nephrotic syndrome: A new weapon against tissue injury. Med Res Rev 2005;25:587-609.
6. Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: Results from a large retrospective cohort study. Circulation 2008;117:224-230.
7. Koomans HA. Pathophysiology of oedema in idiopathic nephrotic syndrome. Nephrol Dial Transplant 2003;18 (Suppl 6):vi30-vi32.
8. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management. Thromb Res 2006;118:397-407.
9. Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997;30:621-631.
10. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
11. Grauer GF, Frisbie DD, Snyder PS, et al. Treatment of membranoproliferative glomerulonephritis and nephrotic syndrome in a dog with a thromboxane synthetase inhibitor. J Vet Intern Med 1992;6:77-81.
12. Center SA, Smith CA, Wilkinson E, et al. Clinicopathologic, renal immunofluorescent, and light microscopic features of glomerulonephritis in the dog: 41 cases (1975-1985). J Am Vet Med Assoc 1987;190:81-90.
13. Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: A review of 137 cases (1985-1992). J Am Anim Hosp Assoc 1996;32:313-322.
14. Green RA, Kabel AL. Hypercoagulable state in three dogs with nephrotic syndrome: Role of acquired antithrombin III deficiency. J Am Vet Med Assoc 1982;181:914-917.
15. Green RA, Russo EA, Greene RT, et al. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome. J Am Vet Med Assoc 1985;186:485-488.
16. Osborne CA, Hammer RF, Resnick JS, et al. Natural remission of nephrotic syndrome in a dog with immune-complex glomerular disease. J Am Vet Med Assoc 1976;168:129-137.
17. Ritt MG, Rogers KS, Thomas JS. Nephrotic syndrome resulting in thromboembolic disease and disseminated intravascular coagulation in a dog. J Am Anim Hosp Assoc 1997;33:385-391.
18. Stone MS, Johnstone IB, Brooks M, et al. Lupus-type "anticoagulant" in a dog with hemolysis and thrombosis. J Vet Intern Med 1994;8:57-61.
19. Vasilopulos RJ, Mackin A, Lavergne SN, et al. Nephrotic syndrome associated with administration of sulfadimethoxine/ormetoprim in a Dobermann. J Small Anim Pract 2005;46:232-236.
20. Jaenke RS, Allen TA. Membranous nephropathy in the dog. Vet Pathol 1986;23:718-733.
21. Wright NG, Nash AS, Thompson H, et al. Membranous nephropathy in the cat and dog: A renal biopsy and follow-up study of sixteen cases. Lab Invest 1981;45:269-277.
22. Biewenga WJ, Gruys E. Proteinuria in the dog: A clinicopathological study in 51 proteinuric dogs. Res Vet Sci 1986;41:257-264.
23. Vilafranca M, Wohlsein P, Leopold-Temmler B, et al. A canine nephropathy resembling minimal change nephrotic syndrome in man. J Comp Pathol 1993;109:271-280.
24. Jacob F, Polzin DJ, Osborne CA, et al. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J Am Vet Med Assoc 2005;226:393-400.
25. Charlesworth JA, Gracey DM, Pussell BA. Adult nephrotic syndrome: Non-specific strategies for treatment. Nephrology (Carlton) 2008;13:45-50.
26. Kronenberg F. Dyslipidemia and nephrotic syndrome: Recent advances. J Ren Nutr 2005;15:195-203.
27. Hess RS, Kass PH, Van Winkle TJ. Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs. J Vet Intern Med 2003;17:489-494.
28. Schachter AD. The pediatric nephrotic syndrome spectrum: Clinical homogeneity and molecular heterogeneity. Pediatr Transplant 2004;8:344-348.
29. Doucet A, Favre G, Deschenes G. Molecular mechanism of edema formation in nephrotic syndrome: Therapeutic implications. Pediatr Nephrol 2007;22:1983-1990.
30. Ghiggeri GM, Artero M, Carraro M, et al. Permeability plasma factors in nephrotic syndrome: More than one factor, more than one inhibitor. Nephrol Dial Transplant 2001;16:882-885.
31. Rostoker G, Behar A, Lagrue G. Vascular hyperpermeability in nephrotic edema. Nephron 2000;85:194-200.
32. Vaden SL. Glomerular diseases. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. St Louis, MO: Saunders Elsevier; 2010:2021-2036.
33. Muller-Peddinghaus R, Trautwein G. Spontaneous glomerulonephritis in dogs. I. Classification and immunopathology. Vet Pathol 1977;14:1-13.
34. Macdougall DF, Cook T, Steward AP, et al. Canine chronic renal disease: Prevalence and types of glomerulonephritis in the dog. Kidney Int 1986;29:1144-1151.
35. Daneschvar HL, Seddighzadeh A, Piazza G, et al. Deep vein thrombosis in patients with chronic kidney disease. Thromb Haemost 2008;99:1035-1039.
36. Slauson DO, Gribble DH. Thrombosis complicating renal amyloidosis in dogs. Vet Pathol 1971;8:352-363.
37. Kauffmann RH, Veltkamp JJ, Van Tilburg NH, et al. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 1978;65:607-613.
38. Vaziri ND, Paule P, Toohey J, et al. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med 1984;144:1802-1803.
39. Rabelink TJ, Zwaginga JJ, Koomans HA, et al. Thrombosis and hemostasis in renal disease. Kidney Int 1994;46:287-296.
40. Kuzi S, Segev G, Haruvi E, et al. Plasma antithrombin activity as a diagnostic and prognostic indicator in dogs: A retrospective study of 149 dogs. J Vet Intern Med 2010;24:587-596.
41. Grauer GF, Greco DS, Getzy DM, et al. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Intern Med 2000;14:526-533.